Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Airway

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44351   clinical trials with a EudraCT protocol, of which   7378   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  3  Next»
    Study title: A placebo controlled dose-finding study with bambuterol in children with reversible obstructive airway disease.A multicentre study performedin Sweden.
    Active substance: BAMBUTEROL HYDROCHLORIDE
    Study summary document link (including results): 09-2017 Study Synopsis.pdf
    View full study record
    Document reference: 46904
    Study title: A single dose of bambuterol (Bambec) intravenous solution and tablets in patients with obstructive airway disease.
    Active substance: BAMBUTEROL HYDROCHLORIDE
    Study summary document link (including results): 09-2020 Study Synopsis.pdf
    View full study record
    Document reference: 46905
    Study title: A retrospective analysis of airway endoscopy in patients less than 1-month old. Ungkanont K. And al; Laryngoscope. 108(11 Pt 1):1724-8, 1998 Nov.A retrospective analysis of airway endoscopy in patients less than 1-month old. Ungkanont K. And al; Laryngoscope. 108(11 Pt 1):1724-8, 1998 Nov.
    Active substance: BARIUM SULPHATE
    Study summary document link (including results):
    View full study record
    Document reference: 22126
    Study title: Airway inflammation in patients with symptoms suggesting asthma but with normal lung function; Investigator initiated study: Publication: P. Rytilä et.al. Eur Respir J 2000; 16:824-830Airway inflammation in patients with symptoms suggesting asthma but with normal lung function; Investigator initiated study: Publication: P. Rytilä et.al. Eur Respir J 2000; 16:824-830
    Active substance: BECLAMETHASONE
    Study summary document link (including results):
    View full study record
    Document reference: 22235
    Study title: Characterization of asymptomatic methacholine airway hyperresponsiveness (MAHR) in children: budesonide or placebo Turbuhaler treated
    Active substance: BUDESONIDE
    Study summary document link (including results): 04-9203 Study Synopsis.pdf
    View full study record
    Document reference: 22932
    Study title: Prophylactic treatment of wheezing in infants with hyper-reactive airways by oral Berotec solution.
    Active substance: FENOTEROL
    Study summary document link (including results): Fenoterol hydrobromide_U86-0413_synopsis.pdf
    View full study record
    Document reference: 27094
    Study title: Study on the obstruction in small airways.
    Active substance: FENOTEROL
    Study summary document link (including results): Fenoterol hydrobromide_U76-0596_synopsis.pdf
    View full study record
    Document reference: 27060
    Study title: Evaluation of optimal effective dose and action duration of ipratropium bromide in reducing bronchospasm in children with reversible chronic obstructive airway disease.
    Active substance: IPRATROPIUM
    Study summary document link (including results):
    View full study record
    Document reference: 30549
    Study title: Evaluation of optimal effective dose and action duration of ipratropium bromide in reducing bronchospasm in children with reversible chronic obstructive airway disease.
    Active substance: IPRATROPIUM
    Study summary document link (including results): Ipratropium bromide_U90-0054_synopsis.pdf
    View full study record
    Document reference: 30699
    Study title: Distribution of radioactive aerosol in the airways of children and adolescents with bronchial hyper-responsiveness. Backer V, Mortensen J. Clin Physiol. 1992 Sep;12(5):575-85.
    Active substance: TECHNETIUM (99m)
    Study summary document link (including results): 2011-09 GE response Venticoll List of published articles.doc
    View full study record
    Document reference: 48276
    Study title: Piva JP, Menna Barreto SS, Zelmanovitz F, Amantea S, Cox P. Heliox versus oxygen for nebulized aerosol therapy in children with lower airway obstruction. Pediatr Crit Care Med 2002;3(1):6-10.Piva JP, Menna Barreto SS, Zelmanovitz F, Amantea S, Cox P. Heliox versus oxygen for nebulized aerosol therapy in children with lower airway obstruction. Pediatr Crit Care Med 2002;3(1):6-10.
    Active substance: HELIUM AND OXYGEN
    Study summary document link (including results):
    View full study record
    Document reference: 29100
    Study title: Sauder RA, Rafferty JF, Bilenki AL, Berkowitz ID. Helium-oxygen and conventional mechanical ventilation in the treatment of large airway obstruction and respiratory failure in an infant. South Med J 1991 May;84(5):646-8.Sauder RA, Rafferty JF, Bilenki AL, Berkowitz ID. Helium-oxygen and conventional mechanical ventilation in the treatment of large airway obstruction and respiratory failure in an infant. South Med J 1991 May;84(5):646-8.
    Active substance: HELIUM AND OXYGEN
    Study summary document link (including results):
    View full study record
    Document reference: 29104
    Study title: Smith SW, Biros M. Relief of imminent respiratory failure from upper airway obstruction by use of helium-oxygen: a case series and brief review. Acad Emerg Med 1999 Sep;6(9):953-6.Smith SW, Biros M. Relief of imminent respiratory failure from upper airway obstruction by use of helium-oxygen: a case series and brief review. Acad Emerg Med 1999 Sep;6(9):953-6.
    Active substance: HELIUM AND OXYGEN
    Study summary document link (including results):
    View full study record
    Document reference: 29106
    Study title: Ulhoa CAG, Larner L. Helium-oxygen (Heliox) mixture in airway obstruction. J Pediatr (Rio J) 2000 Jan-Feb;76(1):73-8.Ulhoa CAG, Larner L. Helium-oxygen (Heliox) mixture in airway obstruction. J Pediatr (Rio J) 2000 Jan-Feb;76(1):73-8.
    Active substance: HELIUM AND OXYGEN
    Study summary document link (including results):
    View full study record
    Document reference: 29110
    Study title: Curtis JL, Mahlmeister M, Fink JB, Lampe G, Matthay MA, Stulbarg MS. Helium-oxygen gas therapy. Use and availability for the emergency treatment of inoperable airway obstruction. Chest 1986 Sep;90(3):455-7.Curtis JL, Mahlmeister M, Fink JB, Lampe G, Matthay MA, Stulbarg MS. Helium-oxygen gas therapy. Use and availability for the emergency treatment of inoperable airway obstruction. Chest 1986 Sep;90(3):455-7.
    Active substance: HELIUM AND OXYGEN
    Study summary document link (including results):
    View full study record
    Document reference: 29074
    Study title: A multi-centre, randomised, double-blind, double-dummy, parallel-group study to determine the clinical equivalence between fluticasone propionate 50μg twice daily delivered via a multidose powder inhaler (MDPI) and the Diskhaler™ in children aged 4-11 years with reversible airways disease
    Active substance: FLUTICASONE
    Study summary document link (including results): Fluticasone-Propionate-FMDT01-ICHE3.pdf
    View full study record
    Document reference: 28432
    Study title: Grosz AH, Jacobs IN, Cho C, Schears GJ. Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population. Laryngoscope 2001;111(9):1512-1514.Grosz AH, Jacobs IN, Cho C, Schears GJ. Use of helium-oxygen mixtures to relieve upper airway obstruction in a pediatric population. Laryngoscope 2001;111(9):1512-1514.
    Active substance: HELIUM AND OXYGEN
    Study summary document link (including results):
    View full study record
    Document reference: 29081
    Study title: Summary of the efficacy and safety and safety of salmeterol 50mcg and fluticasone propionate 100mcg administered in Diskus Dry Powder Inhaler twice daily in steroid experienced children with reversible airways obstruction
    Active substance: FLUTICASONE AND SALMETEROL
    Study summary document link (including results): Fluticasone-Propionate-Sameterol-SAM40121-ICHE3.pdf
    View full study record
    Document reference: 28449
    Study title: DOUBLE-BLIND, 12-WEEK, PARALLEL-GROUP, MULTI-CENTRE TRIAL TO ASSESS FORMOTEROL DRY POWDER 12 UG AND 24 UG DAILY VS. SALBUTAMOL DRY POWDER 1200 UG DAILY IN CHILDREN WITH REVERSIBLE OBSTRUCTIVE AIRWAYS DISEASES
    Active substance: FORMOTEROL
    Study summary document link (including results): FOR258 DP_PD2 Art45 listing 2011.xls
    View full study record
    Document reference: 47832
    Study title: Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis. Respir Med 2006 Jan; Article in press.Martinón-Torres F, Rodriguez-Nuñez A, Martinón-Sánchez JM. Nasal continuous positive airway pressure with heliox in infants with acute bronchiolitis. Respir Med 2006 Jan; Article in press.
    Active substance: HELIUM AND OXYGEN
    Study summary document link (including results):
    View full study record
    Document reference: 29093
    1  2  3  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Jul 20 08:25:49 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA